TORONTO, May 24, 2017 -- Maricann Group Inc. (CSE:MARI) ("Maricann" or the "Company"), a low cost, greenhouse producer of medical cannabis with market leading technological differentiation, is laying down the foundations today for more growth as it breaks ground for its expanding cultivation and production facility in Langton, Ontario.
|
||||||||||
Photos accompanying this announcement are available at:
http://www.globenewswire.com/NewsRoom/AttachmentNg/59594880-514d-469e-9735-5b137c4e04cc
http://www.globenewswire.com/NewsRoom/AttachmentNg/3a72d2e5-611a-4523-a0cc-abf24ba9e989
“Having recently listed publicly, we are now setting the stage for our ongoing physical expansion by way of a major enlargement of our Langton growing facility,” said Ben Ward, CEO of Maricann. “We’re very proud to formally break ground of the first 217,000 sq. ft. of an overall 817,000 sq. ft. greenhouse facility expansion. This expanding facility will give us the scale we need to become one of the world’s leading vertically integrated cannabis companies.”
Maricann originally acquired an 8,000 square foot growing operation in Langton in 2013. Since that time, Maricann has expanded its facility to 44,000 square feet, in which the company currently cultivates, processes and distributes medical cannabis. The new phase of additional construction underway will significantly increase the existing facility’s size.
When Phase 1 is complete in the fall of 2017:
- The expanded Langton facility will be approximately 217,000 square feet, an increase of approximately 833% to the existing domestic facility.
- This expansion increase will drive $80 million in additional annual revenues
- Yield and production will increase 500%, with production of more than 20,000 kilograms by the end of the first year of the expanded facility.
Phase 2, which will start in fourth quarter of 2017, will add an additional 300,000 square feet, an increase of 110% to the same facility, driving even more scale efficiencies.
“Our local team of experts from the food, pharmaceutical and construction sectors help us grow high-quality cannabis plants in Norfolk County, a region widely recognized as Ontario’s garden,” said Jeff Ayotte, Senior Director of Project Management Office. “Our highly energy-efficient growing facility will be operated with low-cost energy supply from both natural gas cogeneration and our active natural gas well on-site. It will be world class once it’s done, building on our deep roots both in the area and in the industry.”
Maricann Milestones
- April 2013, Maricann Inc. is founded in Langton, Ontario, a well-established agricultural region in southwestern Ontario
- March 2014, earned Health Canada licence to cultivate plants
- December 2014, earned Health Canada licence to sell dried cannabis
- January 2015, first dried cannabis sale
- September 2016, earned Health Canada licence to sell cannabis extracts
- October 2016, first sale of extracted cannabis
- December 2016, raised $22 million in capital
- January 2017, commenced sale of clones
- February 2017, raised $10 million in capital
- April 24, 2017, first day of trading
- April 28, 2017, announces Advisory Board of German subsidiary
- May 24, groundbreaking of expanding Langton facility
About Maricann
Maricann is a vertically integrated producer and distributor of marijuana for medical purposes. The company was founded in 2013 and is based in Langton, Ontario, where it operates a cultivation, marijuana extraction and distribution business under federal licence from the Government of Canada. Maricann, which has federal licences to cultivate, process and distribute cannabis, services a patient base with more than 3,000 active patients.
www.maricann.ca
Contact information Shawn Alexander VP Investor Relations [email protected] 416.258.4784 Corporate Headquarters: Maricann Group Inc. (C.MARI) 845 Harrington Court, Unit 3 Burlington Ontario L7N 3P3 Canada Dial Toll Free in North America: 1.844.Maricann (627.4226) International Only: 001.416.916.7145


Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
SK Hynix to Invest $13 Billion in AI Chip Packaging Facility
Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries”
Microsoft Commits $18 Billion to Expand AI and Cloud Infrastructure in Australia
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO
Elon Musk Signals Intel 14A Chips for Tesla’s Terafab AI Semiconductor Venture
Nvidia Pushes 800V Data Center Power Systems to Boost Efficiency and Cut Costs
OPmobility Reports Q1 Revenue Dip Amid Automotive Industry Slowdown
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals
Kakaku.com Stock Surges on EQT Takeover Interest Amid Rising Japan Deal Activity
Florida Launches Criminal Probe Into OpenAI Over FSU Shooting Incident
SK Hynix Reports Record Q1 Profit Surge Driven by AI Memory Chip Demand 



